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Abstract. Since last year of December 2019, a virus Severe Acute Respiratory Syndrome 
coronavirus (SARS-CoV-2), has been identified in Wuhan, China, 2019 Novel Coronavirus 
(COVID-19) Disease is a very scary disease. This disease is a challenge for human as its cure is 
still need to be discovered.  These virus have effected all over the world’s country like America, 
Brazil, Turkey, China, Italy, Iran, India, Canada and Russia etc., this virus first time reported in 
relation to the Huainan Seafood Wholesale Market (South China Seafood City Food Market) in 
Wuhan, China. This market gained media attention after being identified as a point of origin of 
the 2019–2020 coronavirus pandemic.  Severe Acute Respiratory Syndrome coronavirus have 
the common sign & symptoms like pneumonia and show symptoms of fever, headache, joint 
pain, common cold, chills, shortness of breath, cough severe pneumonia, dyspnea, and renal 
insufficiency. The detection of 2019- SCoV-like viruses in tiny size, live wild mammals in a 
market indicates a route of inters species spreading, although the natural loch is not known. 
This theory assembles a study of the molecular biology fundamental of these infectious agents, 
with particular prominence on the nature and identify of viral receptors, viral RNA synthesis, 
and the molecular interactions governing viral assembly. 
 
Keywords: Coronavirus, Pneumonia Transmission, Virus, Viral RNA. 
Abstrak. Dipenghujung akhir tahun Desember 2019, sebuah virus yang dinamakan  Sindrom 
Pernafasan Akut (SARS-CoV-2), telah diidentifikasi di Wuhan, Cina, Coronavirus 2019 
(COVID-19) adalah penyakit yang sangat menakutkan. Penyakit ini merupakan tantangan bagi 
manusia dikarenakan terapi antivirus yang masih belum ditemukan. Virus ini telah 
mempengaruhi seluruh negara di dunia seperti Amerika, Brasil, Turki, Cina, Italia, Iran, India, 
Kanada dan Rusia serta berbaga Negara lainnya. Virus ini pertama kali dilaporkan terjadi di 
Pasar Grosir Makanan Laut Huainan di Wuhan, Cina. Pasar ini mendapat perhatian media 
setelah diidentifikasi sebagai titik asal pandemi coronavirus 2019-2020. Infeksi virus corona 
memiliki tanda & gejala yang sama seperti pneumonia dan menunjukkan gejala demam, sakit 
kepala, nyeri sendi, pilek, menggigil, sesak napas, batuk pneumonia berat, dispnea, dan 
insufisiensi ginjal. Deteksi virus seperti 2019-SCoV dalam ukuran kecil, mamalia liar yang 
dijual di pasar menunjukkan rute asal penyebaran meskipun tidak diketahui secara pasti. 
Bebera teori mengumpulkan studi tentang biologi molekuler yang mendasar dari agen infeksius 
ini, bagaimana sifat dan identifikasi reseptor virus, sintesis RNA virus, dan interaksi molekuler 
yang mengatur perakitan  daur hidup virus. 
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1. Introduction 
Novel Coronavirus is an enveloped, non-segmented, positive-sense single-stranded RNA virus 
genomes. It contains 26-32 kilo bases. Corona means ―crown‖ in Latin, therefore the virus is named 
as corona virus due to its appearance. It contain many protein including phosphorylated 
nucleocapsid(N) protein, spike glycoprotein trimmer (S) protein, membrane (M) protein (a type III 
transmembrane glycoprotein), envelope (E) protein, hemagglutinin-esterase (HE). N protein, is 
buried inside phospholipid bilayers and covered by two different types of spike proteins: (S) that 
can be found in all CoVs, and the HE that exists in some CoVs. The family Coronaviridae includes 
a large number of viruses, found in fish, birds and mammals [1], [2].  
There are approximately 30 acknowledge CoVs that contaminate mammals, poultry, and other 
animals. Alpha and Beta CoVs cause infections in humans. Metamorphic analyses have shown that 
bats and rodents are the gene sources of most αCoVs and βCoVs, while avian species are the gene 
sources of most δCoVs and γCoVs. CoVs have repeatedly crossed species snag and some have 
emerged as important human pathogens. The viruses (SARS-CoV & MERS-CoV) have originated 
from bats and then jumped into another amplification mammalian host. The Himalayan palm civet 
(Paguma larvata) for SARS-CoV and the dromedary camel (Camelus dromedarius) for Middle 
East respiratory syndrome Corona Virus (MERS-CoV), before crossing species barriers to infect 
human [3].                                   
  
Figure 1 Structure of Novel Coronavirus [3] 
2.  History 
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During the end of 2019 and the beginning of 2020, many human cases of novel coronavirus 
infection were reported in relation to the Huainan Seafood Wholesale Market (South China Seafood 
City Food Market) in Wuhan, China. At 9 o’clock, January 7, 2020, the virus was identified as a 
novel coronavirus and officially named by the WHO as Covid-19 [4]. On January 13, 16 and 21 
respectively, Thailand, Japan and Korea confirmed cases was detected of a human infection with 
2019-nCoV from China. On January 22, 2020, a total of 314 confirmed cases have been reported, 
and 6 patients were died in China. [5]. Severe acute respiratory syndrome CoV (SARS-CoV) which 
emerged in China in 2002–2003 to cause a large-scale epidemic [3] and resulted in 8,096 people 
infected with 774 deaths (fatality rate of 9.6%) [6]. Middle East respiratory syndrome CoV (MERS-
CoV) which has caused a persistent epidemic in the Arabian Peninsula since 2012 [7, 8] and killed 
858 people out of the 2,494 infected (fatality rate of 34.4%) [6]. Before December 2019, 6 CoVs 
were known to infect human, including 2 αCoV (HCoV-229E and HKU-NL63) and 4 βCoV 
(HCoV-OC43 [lineage A], HCoV-HKU1 [lineage A], SARS-CoV [lineage B] and MERS-CoV 
[lineage C] [3]. 
3.  Total Cases All Over World  
According to the WHO this scenario shows about the Novel Corona Virus effect till 26
th
 May, 2020 
[9]. 
 Confirmed Cases: 5370375 
 Total Deaths : 344454 
 Total Countries: 216 
        Table 1. Infected World Regions Name by Novel Coronavirus (COVID-19) 
 No World Regions Name Confirmed Cases 
1 Americas 2,454,452 
2 Europe 2,025,176 
3 Eastern Mediterranean 427,832 
4 South-East Asia 203,733 
5 Western Pacific 175,426 
6 Africa 83,044 
 
 
4.  Transmission of Corona virus 
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Novel coronavirus can be transmitted through droplets of different sizes: droplet particles size is >5-
10 μm in diameter they are referred to as respiratory droplets.  Droplet particles size <5μm in 
diameter, they are referred to as droplet nuclei.  According to current evidence, COVID-19 virus is 
primarily transmitted between people through respiratory droplets and contact routes.
 
Transmission 
of the COVID-19 virus can occur by direct contact with infected people and indirect contact with 
surfaces in the immediate environment or with objects used on the infected person (e.g., stethoscope 
or thermometer). Airborne transmission is different from droplet transmission as it refers to the 
presence of microbes within droplet nuclei, which are generally considered to be particles <5μm in 
diameter, can remain in the air for long periods of time and be transmitted to others over distances 
greater than 1 m.  There is some evidence that COVID-19 infection may lead to intestinal infection 
and be present in faeces. However, to date only one study has cultured the COVID-19 virus from a 
single stool specimen. There have been no reports of faecal-oral transmission of the COVID-19 
virus to date [6]. 
 
Figure 2 Transmission of Corona Virus [10] 
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5. Sign and Symptoms of Corona Virus Infection 
Most common symptoms: Fever, Dry cough, Tiredness, Shortness of breath 
 
 
Figure 3 Graphical Sign & Symptoms [6] 
 
Less common symptoms: Aches and Pains, Sore throat, Diarrhea, Conjunctivitis, Headache. 
Serious symptoms: Difficulty breathing or shortness of breath, chest pain or pressure loss of 
speech or movement. Seek immediate medical attention if you have serious symptoms. Always call 
before visiting your doctor or health facility.  People with mild symptoms who are otherwise 
healthy should manage their symptoms at home. On average it takes 5–6 days from when someone 
is infected with the virus for symptoms to show, however it can take up to 14 days. 
6. Genomic characterization of 2019 n human corona virus 
 
Figure 4  Beta Coronavirus Genome Organization [3] [11] 
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Coronavirus genome comprises of 5′ un translated region (5UTR) including 5′ leader sequence, 
open reading frame (ORF) 1a/b (yellow box) encoding non-structural proteins (NSP) for 
replication, structural proteins including envelop (orange box), membrane (red) and nucleoprotein 
(cyan box), accessory proteins (purple boxes) [11]. 
7. Diagnosis 
7.1 Quantitative RT-PCR Assay  
A typical 20 mL monoplex RT-PCR assay contained 5 μL of 4X master reaction mixture (TaqMan 
Fast Virus 1-Step Master Mix, Thermo Fisher), 0.5 μmol/L of forward primer, 0.5 μmol/L of 
reverse primer, 0.25 μmol/L of probe, and 4 μl of RNA sample. RT-PCR reactions were conducted 
by a thermal cycler (ViiA7 Real-Time PCR system, Thermo Fisher) with the following conditions: 
reverse transcription at 50
֯
C for 5 min, inactivation of reverse transcriptase at 95
֯
C for 20 s, 40 
cycles of PCR amplification (Denaturing at 95
֯
C for 5 s; Annealing/Extending at 60
֯
C for 30 s). The 
time for each RT-PCR run was about 1 h and 15 min [12], [13]. 
7.2 Western blot 
Producer cells (spike-transfected 293T) were lysed in 1%SDS, 150mM NaCl, 50mM Tris-HCl, 
5mM EDTA and clarified by centrifugation at 14000xG for 20 minutes. Pseudotyped particles were 
concentrated from builder cell lysates that were overlaid a 10% OptiPrep cushion in PBS (Sigma) 
and centrifuged at 20,000× g for 2 hours at 4 °C. Lysates and concentrated particles were analyzed 
for FLAG, GAPDH and/or VSV-m expression on 10% Bis-Tris PAGE gel [14]. 
7.3  Analysis of RNA  
 For electrophoretic analysis virion RNA was denatured in gIyoxal and dimethylsulfoxide, and 
electrophoresed on 1% agarose gels in a vertical slab apparatus of 10 cm× 14 cm × 3 mm 
dimensions using the method of McMASTER and CARMICIIAEL. Gels were dehydrated in two 
successive 30 minutes baths of 100 per cent methanol, compressed by blotting to a thickness of < 1 
ram, and exposed to X-Omat film. For T1-oligonucleotide fingerprint analysis virion genomic RNA 
species were isolated by rate zonal sedimentation on preformed linear gradients of 30 to 15 per cent 
(w/w) sucrose containing 0.1 percent SDS, 0.02 M Tris-hydroehloride, pH 7.4, 0.1 M NaCI, and 
0.001 M EDTA, for 1.5 hours at 1l0,000 g in a Sorvall 650 rotor, at 25 ° C. Fractions (0.2 rot) were 
collected and the distribution of radioactivity was determined by Cerenkov radiation. RNA was 
precipitated at -20°C for 16 hours by adding 2 volumes of 100 percent ethanol and 0.1 volume of 2 
M sodium acetate. RNA was digested to completion with RNAse T1 and electrophoresed in two 
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dimensions on polyacrylamide gels according to the method of DEWECHTER and FIERS as 
modified [15]. 
7.4   Cell Culture and Cell Lines 
Human hepatocellular carcinoma cells Huh-7, Huh-7.5 cells and sub clones were maintained in 
Dulbecco’s modified Eagle medium (Invitrogen, Karlsruhe, Germany) supplemented with 10% fetal 
bovine serum, 2 mM L-glutamine, 1% (v/v) nonessential amino acids, 100 U/ml penicillin, and 100 
μg/ml streptomycin. Cells harboring small hairpin RNA (shRNA) were kept in the presence of 5 
g/mL blasticidin. The Huh-7.5-CypAKD cell line, Huh-7D, Huh-7 Lunet cells were described. Cell 
viabilities were determined by CellTiter- Glo Luminescent Cell Viability Assay [16]. 
7.5  Inhibitory Effect of Compound 
HCoV-229E viruses expressing Renilla luciferase (LUC) or Green Fluorescent Protein (GFP) 
reporter genes were used to examine the inhibitory effect of compounds. Generally, Huh-7.5 cells 
were infected with MOI=0.1 and incubated for two days in the presence of increasing 
concentrations of inhibitor in the culture medium. Viral replication was determined by measuring 
Renilla luciferase activity or GFP fluorescence. 
7.6  Antiviral Assay 
Antiviral activities of the candidate compounds were examined using CRFK cells infected with 
different concentrations of FIPV with two biological and three technical replicates. The CRFK cells 
were seeded at 1×105 cells/mL (100 μl/well) onto a 96-well plate for the immunoperoxidase 
monolayer assay (IPMA), and at 5×104 cells/well into a 24-well plate for qPCR-based detection of 
the virus. The inhibitory activities of each compound at all the tested concentrations were compared 
with ribavirin, a broad-spectrum antiviral drug, and lopinavir, an HIV-protease inhibitor, as positive 
control drugs, for 24 h. A set of wells designated as negative control, consisting of no inhibitor with 
1% DMSO control, no virus control, and no inhibitor or virus control, was included in each 
experiment. Three conditions were generated for each tested compound [17]. 
7.7   Transmission Electron Microscopy  
Supernatant from human airway epithelial cell cultures that showed cytopathic effects was 
collected, inactivated with 2% paraformaldehyde for at least 2 hours, and ultracentrifuged to 
sediment virus particles. The enriched supernatant was negatively stained on film-coated grids for 
examination. Human airway epithelial cells showing cytopathic effects were collected and fixed 
with 2% paraformaldehyde–2.5% glutaraldehyde and were then fixed with 1% osmium tetroxide 
dehydrated with grade ethanol embedded with PON812 resin. Sections (80 nm) were shear from 
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resin block and smear with uranyl acetate and lead citrate, one by one. The negative stained grids 
and ultrathin sections were observed under transmission electron microscopy [16]. 
7.8  Chest Radiography 
 In the early stage of pneumonia cases, chest images show multiple small patchy shadows World 
Journal of Pediatrics1 3 and interstitial changes, remarkable in the lung periphery. Severe cases can 
further develop to bilateral multiple ground-glass opacity, infiltrating shadows, and pulmonary 
consolidation, with infrequent pleural effusion. Chest CT scan pulmonary lesions are shown more 
clearly by CT, including ground-glass opacity and segmental consolidation in bilateral lungs, 
especially in the lung periphery. In children with severe infection, multiple lobar lesions may be 
present in both lungs [16]. 
8.  Precaution/ Alternative Treatment of Novel Coronavirus 
8.1  Immunosuppressant Drug 
Cyclophilins and FK506-binding (FKBPs) proteins as cellular interaction partners of the viral Nsp1 
protein and the cyclophilin-binding immunosuppressive drug cyclosporin A (CsA) as a replication 
inhibitor of the various human and animal CoVs including SARS-CoV, NL63, 229E and Feline 
CoV. CsA derivatives Alisporivir (ALV), NIM811 and further compounds inhibit replication of 
NL63 and that Cyclophilin A is an essential cellular molecule required for virus replication [17]. 
8.2  Antiviral Therapy 
There are no effective antiviral drugs for children at present. Interferon-α2b nebulization can be 
applied, and the recommended usage is as follows: 
i. Interferon-α2b nebulization 100,000–200,000 IU/kg for mild cases, and 200,000–400,000 
IU/kg for severe cases, two times/day for 5–7 days. 
ii. Lopinavir/Litonavir (200 mg/50 mg) The recommended doses: weight 7–15 kg, 12 mg/3 
mg/kg; weight 15–40 kg, 10 mg/2.5 mg/kg; weight > 40 kg, 400 mg/100 mg as adult each 
time, twice a day for 1–2 weeks. Although, the efficacy, treatment course and safety of the 
above drugs remain to be determined. 
iii. Ribavirin, Oseltamivir, Favipiravir, Remdesivir, This drugs also used for the alternative 
Treatment of covid-19.  
 
8.3  Immunomodulating Therapy 
i. Intravenous methylprednisolone (1–2 mg/kg/day) is recommended for 3–5 days, but not for 
long-term use. 
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ii. Intravenous immunoglobulin can be used in severe cases when indicated, but its efficacy 
needs further evaluation. The recommended dose is 1.0 g/kg/day for 2 days, or 400 mg/kg/ 
day for 5 days [18]. 
9.  Prevention and Treatment According to the WHO 
a. The virus does not resolve in the air but on the ground, so it is not transmitted through the 
air. 
b. When the virus falls on the surface of the metal, it will live for 12 hours, so hands should be 
washed with soap and water well. 
c. When it falls on the textile for a period of 9 hours, the Corona virus remains so washing 
clothes or exposure to sunlight for two hours is enough to kill it. 
d. The virus lives on the hands for about 10 minutes, so sticking to an alcohol sterilizer in the 
pocket will do the trick of prevention. 
e. If the virus is exposed to a temperature of 27  C, then it will die, because it does not live in 
hot areas. 
f. Drinking hot water and exposure to sunlight activates resistance to the virus, so you should 
avoid ice cream and prevents them from leaking into lungs. 
g. Gargling with warm, salt water kills the tonsils’ germs and prevents them from leaking into 
the lungs. [19], [20] 
10.  Discussion 
COVID-19 is very dangerous disease for the human being. This virus is spreading very quickly 
through the contact like handshakes, sneezes etc. This disease is pandemic and whole world is 
suffering from it. Cure of this disease is still not known therefore social distancing is employed in 
countries. The disease not only drastically affected in human health but also affected financials.  
According to the WHO guidelines, here we mention the prevention and control. This review brief 
about the structure of virus, prevention and control methods, number of the patients and total deaths 
caused by the novel corona. This review may also be helpful in the diagnosis of the patients and 
prevention of other human beings. 
11. Conclusions  
A review of the "Novel corona virus 2019: a recent update" have been beneficial for the patients 
and human beings. In this, the study of novel coronavirus updates the precaution and general 
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knowledge of the novel corona virus and here guidelines according to the WHO has been added and 
basic thinks are available for the cure and prevention of the Novel corona virus. 
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